Company intelligence / Profile preview

Dermazone Solutions

Ownership: Private
Development stage: Other

Overview

Dermazone offers a broad portfolio of science-backed cosmeceutical and healthcare products for skin and body concerns. The company leverages proprietary nanotechnology platforms for enhanced product delivery and efficacy. Their products are widely available in clinics and pharmacies across Saudi Arabia and internationally. They have over 20 years’ experience with more than 200 products in their portfolio.

Therapeutic areas: DermatologyOther
Modalities: NanoparticleExosome-based therapySmall moleculeBiologicNutraceutical
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Dermazone Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermazone Solutions.

Explore the full profile